Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTern Regulatory News (TERN)

Share Price Information for Tern (TERN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.60
Bid: 2.50
Ask: 2.70
Change: -0.20 (-7.14%)
Spread: 0.20 (8.00%)
Open: 2.85
High: 2.85
Low: 2.60
Prev. Close: 2.80
TERN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of Court Meeting & GM & Lapsing of Scheme

21 Jul 2022 13:30

RNS Number : 3388T
Pires Investments PLC
21 July 2022
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

FOR IMMEDIATE RELEASE

21 July 2022

Recommended All-Share Offer

for

Pires Investments plc ("Pires")

by

Tern plc ("Tern")

proposed to be implemented by means of a Court-sanctioned scheme of arrangement under Part 26 of the Companies Act 2006

Results of Court Meeting and General Meeting and Lapsing of Scheme

On 1 June 2022, it was announced that the Tern Directors and Pires Directors had reached agreement on the terms of a recommended all-share offer by Tern for the issued and to be issued share capital of Pires, proposed to be effected by means of a court-sanctioned scheme of arrangement (the "Scheme") between Pires and Pires Shareholders under Part 26 of the Companies Act 2006 (the "Acquisition").

Earlier today, Pires convened the Court Meeting and General Meeting in connection with the Acquisition.

At the Court Meeting, 60 out of 75 Scheme Shareholders present and voting (whether in person or by proxy) voted in favour of the Scheme, representing 53.50 per cent. in value of the Scheme Shares. While the majority of Scheme Shareholders voting and present at the Court Meeting voted in favour of the Scheme, this did not meet the requirement that Scheme Shareholders voting and present at the Court Meeting representing 75 per cent. or more in value of the Scheme Shares held by such Scheme Shareholders must vote in favour of the Scheme.

At the General Meeting, 53.75 per cent. of the Pires Shareholders present and voting (whether in person or by proxy) voted in favour of the Special Resolution, which was below the minimum threshold (75 per cent. of those shares voted) needed to approve the Special Resolution.

Accordingly, certain of the conditions to the Scheme were not satisfied and the Scheme has lapsed.

The Court Hearing to sanction the Scheme, which was expected to be held on or around 28 July 2022, will now not take place.

As a result, Pires is no longer in an offer period as defined by the City Code on Takeovers and Mergers (the "Code").

Voting results of the Court Meeting

The table below sets out the results of the poll at the Court Meeting. Each Scheme Shareholder, present in person or by proxy, was entitled to one vote per Scheme Share held at the Voting Record Time.

 

Results of Court Meeting

No. of Scheme Shares voted

% of Scheme Shares voted*

No. of Pires Shareholders who voted

% of Pires Shareholders who voted*

No. of Scheme Shares voted as % of issued share capital*

For

53,813,889

53.50%

60

80.00%

31.57%

Against

46,765,049

46.50%

15

20.00%

27.44%

Total

100,578,938

-

75

-

59.01%

* Rounded to two decimal places

Voting results of the General Meeting

The table below sets out the results of the poll at the General Meeting. Each Pires Shareholder, present in person or by proxy, was entitled to one vote per Pires Share held at the Voting Record Time.

 

For**

Against

Total

Special resolution

No. of votes

% of votes*

No. of votes

% of votes*

No. of votes

Approval of the implementation of the Scheme

68

53.75%

15

46.25%

100,822,109

Amendments to the articles

68

53.75%

15

46.25%

100,822,109

Re-registration as a private company

67

53.74%

16

46.26%

100,822,109

* Rounded to two decimal places

** Includes discretionary votes

 

The total number of Pires Shares in issue at the Voting Record Time was 170,456,642. Consequently, the total voting rights in Pires at the Voting Record Time were 170,456,642.

Capitalised terms used but not otherwise defined in this announcement have the meanings given to them in the Scheme Document published on 28 June 2022 in relation to the Acquisition.

 

 

Enquiries:

 

Pires Investments plc

Nicholas Lee, Non-Executive Director

 

+44 (0) 20 3368 8961

Cairn Financial Advisers LLP

Financial Adviser, Rule 3 Adviser and Nominated Adviser to Pires

James Lewis / Liam Murray / Ludovico Lazzaretti

 

+44 (0) 20 7213 0880

Peterhouse Capital Limited

Joint Broker to Pires

Duncan Vasey / Lucy Williams

 

+44 (0) 20 7469 0935

Tennyson Securities

Joint Broker to Pires

Peter Krens

 

+44 (0) 20 3167 7221

Yellow Jersey PR

PR advisers to Pires

Sarah Hollins / Henry Wilkinson / Annabelle Wills

 

+44 (0) 20 3004 9512

 

Notices related to the financial adviser

Cairn, which is authorised and regulated by the FCA in the UK, is acting as financial adviser and Rule 3 adviser exclusively for Pires and no one else in connection with the Acquisition and the matters set out in this announcement and will not be responsible to any person other than Pires for providing the protections afforded to clients of Cairn, nor for providing advice in relation to the Acquisition, the content of this announcement or any matter referred to herein. Cairn's responsibilities as Pires' Nominated Adviser under the AIM Rules for Companies and AIM Rules for Nominated Advisers are owed solely to London Stock Exchange and no other person. Cairn has not authorised and is not making any representation or warranty, express or implied, as to the contents of this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBDGDRSBDDGDB
Date   Source Headline
25th Apr 20247:00 amRNSExercise of warrants held in Wyld Networks
12th Apr 20247:00 amRNSPlacing to raise £420,000
9th Apr 20247:00 amRNSTalking Medicines record revenue bookings in Q1 24
21st Mar 20247:00 amRNSOnline Investor Presentation and Q&A Session
5th Mar 20247:00 amRNSKonektio Administration
7th Feb 20247:00 amRNSDevice Authority Fund Raise
1st Feb 20247:00 amRNSTalking Medicines Fundraise
31st Jan 20245:32 pmRNSTotal Voting Rights
24th Jan 20247:00 amRNSPlacing to raise £400,000
15th Jan 20243:22 pmRNSHolding(s) in Company
28th Dec 20237:00 amRNSCompletion of Tranche One of the DA Fund raise
27th Dec 20237:00 amRNSDevice Authority Fund raise
29th Nov 20237:00 amRNSKonektio update
24th Nov 20237:00 amRNSInvestor Webinar Recording
21st Nov 20237:00 amRNSCompany and Portfolio Update
15th Nov 20237:00 amRNSOnline Investor Presentation and Q&A Session
8th Nov 20237:00 amRNSKonektio update
26th Sep 202312:19 pmRNSResult of GM
31st Aug 20237:00 amRNSNotice of General Meeting
16th Aug 20237:00 amRNSInterim results for the six months to 30 June 2023
10th Aug 20237:00 amRNSBoard and Management Restructuring
4th Aug 20231:33 pmRNSStatement re Share Price Movement
4th Jul 20237:00 amRNSDevice Authority convertible loan note extension
30th Jun 20235:00 pmRNSTotal Voting Rights
29th Jun 202310:09 amRNSResult of AGM and Directorate Change
28th Jun 20237:00 amRNSDevice Authority - Winner of Microsoft Award
12th Jun 202311:35 amRNSFunding facility
31st May 20237:00 amRNSResults for the year ended 31 December 2022
26th May 20237:00 amRNSKonektio Fundraise
23rd May 20237:00 amRNSNotice of Final Results & Investor Q&A Session
25th Apr 20237:00 amRNSKonektio Fundraise
18th Apr 20237:00 amRNSPortfolio Update and Investor Presentation
31st Mar 20239:00 amRNSWyld Networks Q4 2022 Interim Report
13th Mar 20237:45 amRNSWyld Networks SEK 9.2 million Purchase Order
13th Mar 20237:00 amRNSStatement regarding Silicon Valley Bank
10th Feb 20234:35 pmRNSPrice Monitoring Extension
8th Feb 20238:49 amRNSInvestor webinar recording
7th Feb 20237:00 amRNSOnline Investor Presentation and Q&A Session
2nd Feb 202311:08 amRNSProposed Wyld Networks Directorate Change
25th Jan 20237:00 amRNSPortfolio Update & Investor Presentation
12th Jan 20237:30 amRNSWyld Networks SEK 12.6 million Purchase Order
30th Dec 20221:00 pmRNSTotal Voting Rights
22nd Dec 20222:31 pmRNSFurther re. Wyld Networks Warrant Exercise
22nd Dec 20227:00 amRNSKonektio Secondment
21st Dec 20223:14 pmRNSHolding(s) in Company
13th Dec 20227:00 amRNSWyld Networks Warrant Exercise
8th Dec 20227:45 amRNSLaunch of Wyld Networks Satellite IoT Network
8th Dec 20227:00 amRNSSubscription to raise £1.5 million
2nd Dec 20227:00 amRNSDevice Authority Contract Wins
30th Nov 20227:45 amRNSWyld Networks Q3 2022 Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.